Skip to main content

Day: December 6, 2021

CHMP recommends EU approval of Actemra/RoActemra to treat patients with severe COVID-19

Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase III studies The European Commission is expected to make a final decision regarding approval in the near futureBasel, 06 December 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended extending the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. A final decision regarding the approval of Actemra/RoActemra is expected from the European Commission in the near future. “As COVID-19 cases in Europe rise and with pressure on hospitals likely to...

Continue reading

Brookmount Explorations, Inc. Finalizes Development Plan and Budget for Expansion of Canadian Drill Program and Preparation for Production

Los Angeles, California, Dec. 06, 2021 (GLOBE NEWSWIRE) — Brookmount Explorations, Inc. (OTC PINK: BMXI) (“Brookmount”, The Company”), a Nevada incorporated company is pleased to announce that it has finalized its development plan and budget to expand the drill program for “Moosehorn” its recently acquired gold property in the Canadian area of the Tintina gold belt, and to prepare the property for initial production. The Moosehorn property, which comprises 4,300 HA of high-quality gold area, has to date, a confirmed NI 43-101 resource of 39,000 oz. Au. and The Company is planning to extend the drill intensity and depth to upgrade the confirmed resource to 100,000 oz. Au. Additionally, a plan has been drawn up to upgrade and complement existing on-site infrastructure and hire additional workforce to prepare Moosehorn for initial...

Continue reading

Jerome Baker Designs and FDCTech Collaborate to Bring Luxury Glass Digital Art to Global Crypto Audience

Irvine, CA, Dec. 06, 2021 (GLOBE NEWSWIRE) — FDCTech, Inc. (“FDC” or the “Company,” OTCQB: FDCT), a fully integrated financial technology company with a full suite of digital financial services solutions, today announced a collaboration agreement to create the NFT Venture where Jerome Baker Designs will create unique digital art pieces and corresponding physical assets on the Ethereum blockchain. The partnership will commence with an upcoming release of original works developed by its founder Jason Harris, who has created the most unique and rare luxury artwork on the bongs, bubblers, and pipes. The story of Jerome Baker Designs began when founder Jason Harris was blessed enough to apprentice under Bob Snodgrass, Godfather of artistic hard glass and founder of the modern pipe-making industry. Jerome Baker...

Continue reading

Borqs Technologies’ Auditor is Located in the U.S. and Registered with the PCAOB, and is Accessible by the PCAOB for Inspection and Investigation

SANTA CLARA, Calif., Dec. 06, 2021 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”, or the “Company”), a global provider of 5G semiconductor chip design, Internet of Things (IoT) solutions, and innovative clean energy with operations in the United States, India and China, today announced that the Company’s current independent audit firm, YU Certified Public Accountant P.C., is licensed and located in the State of New York, registered with the Public Company Accounting Oversight Board (“PCAOB”) and is accessible for inspection or investigation by the PCAOB, as required by the Securities and Exchange Commission’s (the “SEC”) newly finalized rules of the Holding Foreign Companies Accountable ACT (“HFCAA”). https://www.sec.gov/news/press-release/2021-250. Therefore, the Company does not believe that it will be subject...

Continue reading

Collegium Ranks as a Top Place to Work for 2021 by The Boston Globe

STOUGHTON, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that it has been named one of the Top Places to Work in Massachusetts in The Boston Globe’s 14th annual employee-based survey. Top Places to Work recognizes the most admired workplaces in the state voted on by the people who know them best—their employees. The survey measures employee opinions about their company’s culture and values, training and development programs, employee engagement initiatives, pay, benefits, and more. “We are honored to be recognized by The Boston Globe as one of the top places to work in 2021, which is even more meaningful as it stems from employee feedback on the Company,” said Joe Ciaffoni, President...

Continue reading

OM Holdings International, Inc. Reports Record Results for Fiscal Year-End August 31, 2021

Company Remains profitable with a Net Income of $1.7M Company Increases Net Income by 10% Earning Higher Margins Company Expects OTCQX Uplisting to be Announced within Days MIAMI, Dec. 06, 2021 (GLOBE NEWSWIRE) — OM Holdings International Inc. (OTC Pink: OMHI) an owner and operator of OneMart super merchandising stores and Builders Depot in the British Virgin Islands and the parent of its technology subsidiary, Rydeum Caribbean, Inc. today announced its financial results for the fiscal year ended August 31,2021. Year End Results and Milestones (As compared to year-end August 31, 2020):Net income increased 10 percent to $1,710,179, an increase of $155,138 Earnings per share remains unchanged at $0.04 Net margins increased due to higher food service and yacht provisioning sales Total revenue increased 2.5 percent to $28,898,969,...

Continue reading

Atossa Therapeutics Completes Pre-IND Meeting with U.S. Food & Drug Administration

Input Received on Pathway for Proprietary Z-Endoxifen to Treat Breast Cancer in Neoadjuvant Setting SEATTLE, Dec. 06, 2021 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative proprietary medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, today announces that it has completed a pre-investigational new drug (PIND) meeting with the FDA. The purpose of the meeting was to obtain input from the FDA on pre-clinical, clinical, manufacturing and regulatory matters in the U.S. for Atossa’s proprietary Z-endoxifen to treat breast cancer in the neoadjuvant (prior to surgery) setting. “Holding a PIND meeting is a critical milestone in the regulatory pathway,” said Dr. Heather Fraser, Atossa’s VP Clinical, Regulatory...

Continue reading

Urbanimmersive Acquires Virtual Access Tours

SAINT-HUBERT, Quebec, Dec. 06, 2021 (GLOBE NEWSWIRE) — Urbanimmersive Inc. (“Urbanimmersive”, the “Company” or “UI”) (TSX VENTURE: UI) (OTCQB: UBMRF) is pleased to announce having completed the acquisition of all the limited partnership interests of the real estate photography agency Virtual Access Tours LP (‘VAT’) for a purchase price of $CAD 961k ($449k paid in cash and $513k paid through the immediate issuance of 585,829 shares of the Company at a price of $0.875 per share) plus contingent share payments (earn-outs) totaling up to $US 450k, with up to $US 225k payable in 12 months and up to $US 225k payable in 24 months, both share payments being conditional on VAT minimum revenue growth milestones to be met over the next two years. All shares issued today are subject to a 12-month lock-up period until December 3rd,...

Continue reading

Liquid Media Signs Definitive Agreement to Acquire iGEMStv

VANCOUVER, British Columbia, Dec. 06, 2021 (GLOBE NEWSWIRE) — Liquid Media Group Ltd. (“the Company,” “Liquid Media” or “Liquid”) (Nasdaq: YVR) today announced that, further to its press release dated June 9, 2021, it has executed a definitive agreement to acquire iGEMStv, Inc. (“iGEMStv”), which provides the most comprehensive content recommendation engine on the market. The closing is expected to be completed in the coming days as remaining customary closing conditions are fulfilled, and adds another key asset in stage IV of Liquid’s four-stage business engine, a powerful solution to help professional film, television and video creators/producers outside the major studio system achieve sustainable growth. “iGEMStv is an important tool for discoverability, curation, recommendation and monetization,” said Ronald Thomson, CEO of...

Continue reading

Sage announces 2021 winners of 3rd annual Circle of Excellence Accounting Awards

Annual industry awards recognize the best accounting and bookkeeping professionals in Canada TORONTO, Dec. 06, 2021 (GLOBE NEWSWIRE) — Sage (FTSE: SGE), the market leader in cloud business management solutions, today announced the 2021 Sage Circle of Excellence Accounting Awards winners. Over the past 20 months, many businesses have shifted to serving their clients virtually and in new ways. Accountants and bookkeepers not only embraced remote working during this time, they were also committed to providing advisory services to guide clients through changing government regulations and what it meant for their business. The 2021 awards program celebrates accountants and bookkeepers in Canada and their important role for small businesses, as they provided valuable counsel and support to help businesses not only navigate the financial...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.